Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 8,476 | 2,450 | 5,095 | 1,396 | 1,937 |
| Gross Profit | 8,476 | 2,450 | 5,095 | 1,396 | 1,937 |
| Operating Expenses | 14,187 | 15,166 | 12,401 | 11,420 | 13,645 |
| Operating Income | -5,711 | -12,716 | -7,306 | -10,024 | -11,708 |
| Other Income | 54 | 43 | 19 | 10 | 11 |
| Pre-tax Income | -5,657 | -12,673 | -7,287 | -10,014 | -11,697 |
| Net Income Continuous | -5,657 | -12,673 | -7,154 | -10,014 | -11,697 |
| Minority Interests | -19 | -18 | N/A | 0 | 0 |
| Net Income | $-5,638 | $-12,655 | $-7,147 | $-10,014 | $-11,697 |
| EPS Basic Total Ops | -0.08 | -0.18 | -0.10 | -0.14 | -0.17 |
| EPS Basic Continuous Ops | -0.08 | -0.18 | -0.10 | -0.14 | -0.17 |
| EPS Diluted Total Ops | -0.08 | -0.18 | -0.10 | -0.14 | -0.17 |
| EPS Diluted Continuous Ops | -0.08 | -0.18 | -0.10 | -0.14 | -0.17 |
| EBITDA(a) | $-4,964 | $-11,965 | $-7,139 | $-9,887 | $-11,579 |